Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |